Fortress Biotech, Inc.
FBIO
$2.72
$0.010.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -100.42% | 2,903.48% | -167.30% | -62.22% | 246.32% |
| Total Depreciation and Amortization | -12.80% | 5.36% | 0.00% | 0.09% | -2.94% |
| Total Amortization of Deferred Charges | -84.67% | 329.20% | 6.27% | -29.27% | 52.88% |
| Total Other Non-Cash Items | -118.44% | 4,888.03% | 107.88% | 76.05% | -354.12% |
| Change in Net Operating Assets | -196.15% | 616.32% | -138.36% | 39.39% | -228.17% |
| Cash from Operations | -129.08% | 1,725.09% | -105.30% | 77.83% | -40.88% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -100.00% | -52.84% | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -100.00% | -52.84% | 422.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 200.00% | -26,452.73% | 142.31% | -- | 100.00% |
| Issuance of Common Stock | -83.87% | 249.03% | -77.16% | 191.91% | -45.07% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 100.00% | -- | -- | 100.00% | 23.33% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -60.89% | 233.45% | -92.24% |
| Cash from Financing | 100.33% | -579.95% | -62.14% | 233.38% | -91.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -133.59% | 2,680.96% | -157.78% | 169.79% | -150.24% |